Canadian regulatory authority Health Canada has approved Valeant Pharmaceuticals International subsidiary Valeant Canada's new drug submission of Jublia for the treatment of onychomycosis. Jublia is designated for the treatment of mild to ...
Tags: Fungal Drug, Medicine
Yantai Dongcheng Biochemicals Co., Ltd. (SZSE: 002675) revealed that contracts have been inked with the Yantai Economic and Technological Development Area and PLA Second Military Medical University for joint construction of new anti-fungal ...